#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperoxaluria Chronic inflammatory demyelinating polyradiculoneuropathy Small cell lung cancer recurrent Cholangitis sclerosing Meningitis meningococcal Central nervous system neoplasm Hereditary hypophosphataemic rickets Fusarium infection Hepatitis D Palmar-plantar erythrodysaesthesia syndrome Small for dates baby Focal segmental glomerulosclerosis Idiopathic inflammatory myopathy Retinal dystrophy Lung adenocarcinoma More trials…

    Learn about Rare Diseases

    Mitochondrial myopathy – Diagnostics Nodal marginal zone B-cell lymphoma Ewing’s sarcoma recurrent – Diagnostics Mantle cell lymphoma stage II – Trials in Disease Haemophilia B without inhibitors – Treatment Turner’s syndrome – Basic Information Rhabdomyosarcoma recurrent – Basic Information Pemphigus – Life with Disease Alport’s syndrome – Basic Information Congenital generalised lipodystrophy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AZD0516 Hydrocortisone Ph. Eur. ELTANEXOR Levothyroxine Sulfamethoxazole Mdna11 Amlitelimab Oxybuprocaine Anhydrous Glucose Bp ZUNIBERGENE ROCPARVOVEC Crizotinib L-Threonine Benserazide Hydrochloride Ly3473329 Dmd06-Mab Mcla-129 LY3841136 SODIUM Sacituzumab Tirumotecan Edotreotide Pitavastatin Calcium More therapies…

    Learn about Your Condition

    Cardiac failure acute Testicular leiomyosarcoma Bladder cancer Endometrial cancer metastatic Lichen planus Anal incontinence Cystic fibrosis Cirrhosis alcoholic Vulvovaginal discomfort Adenovirus infection Asthmatic crisis Pyrexia Renal cancer recurrent Immune-mediated enterocolitis Hysterectomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Sequential Treatment with Gemcitabine, Paclitaxel, and FOLFIRINOX for Patients with Locally Advanced Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Levoleucovorin
    • Irinotecan Hydrochloride Trihydrate
    • Fluorouracil
    France

  • Study on Filgrastim for Patients with Severe Bullous Drug Eruptions: Lyell and Stevens-Johnson Syndromes

    Recruiting

    4 1 1
    Investigated Diseases:
    • Stevens-Johnson syndrome
    • Toxic epidermal necrolysis
    Investigated Drugs:
    • Glucose Monohydrate
    • Filgrastim
    France

  • Study of IMC-M113V for Patients with Chronic HIV Infection Who Are Virologically Suppressed

    Recruiting

    2 1 1
    Investigated Drugs:
    • Bispecific Protein With A High-Affinity T-Cell Receptor Domain Fused To An Antibody Single-Chain Variable Fragment Against Cd3
    Belgium Spain

  • Study on the Safety and Tolerability of TUB-040 for Patients with Platinum-Resistant Ovarian Cancer or Relapsed/Refractory Non-Small Cell Lung Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Adenocarcinoma
    • Ovarian cancer
    • Non-small cell lung cancer
    Investigated Drugs:
    • Tub-040
    Belgium Germany Romania Spain

  • Study of tazemetostat combined with lenalidomide and rituximab in adult patients with relapsed or refractory follicular lymphoma

    Recruiting

    3 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Tazemetostat
    • Lenalidomide
    • Rituximab
    Belgium France Germany Hungary Italy Poland +1

  • Study on the Use of Gallium Citrate Ga-68 for Diagnosing Chronic Infections in Artificial Hip and Knee Joints

    Recruiting

    2 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Gallium Citrate Ga-68
    France
Previous Page
1 … 336 337 338 339 340 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!